Memapsin-2 also known as the β-amyloid cleaving enzyme (BACE1) is the initial enzyme that leads to a cascade that creates β-amyloid (Aβ) from cleavage of the amyloid precursor protein (APP). The formation of Aβ is the pathogenic step of the Aβ theory which is the most widely held theory for the pathogenesis of Alzheimer's disease (AD). Both APP and BACE1 are membrane proteins that have their own endocytotic signals where in vivo studies have shown that ectodomain BACE (M2 ED ) is still endocytosed despite lacking its endocytotic signal. The dependence of M2 ED on the endocytotic signal in APP was verified when no internalization was present with an APP mutant lacking the signal. Trials in which no APP was present showed little to no internalized M2 ED which is interpreted that M2 ED which has no endocytotic signal interacts with APP and then the proteins are co-internalized. Initial hypothesizes suggested that the active site of M2 ED was responsible for this interaction. Experiments were completed in which M2 ED was incubated with an active site inhibitor and then added to APP transfected cells with these experiments showing little to no decrease in internalization.
